+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Acute Repetitive Seizures Market Size, Share & Trends Analysis Report By Product (USL-261, NRL-1, AZ-002, Diastat Rectal Gel), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) And Segment Forecasts, 2025 - 2030- Product Image
Acute Repetitive Seizures Market Size, Share & Trends Analysis Report By Product (USL-261, NRL-1, AZ-002, Diastat Rectal Gel), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) And Segment Forecasts, 2025 - 2030- Product Image
New

Acute Repetitive Seizures Market Size, Share & Trends Analysis Report By Product (USL-261, NRL-1, AZ-002, Diastat Rectal Gel), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 100 Pages
  • January 2025
  • Region: Global
  • Grand View Research
  • ID: 4700906
Description Jump to:
The global acute repetitive seizures market size is estimated to reach USD 6.48 billion by 2030, expanding at a CAGR of 12.7% from 2025 to 2030. Rise in the number of initiatives to increase awareness about epilepsy is the major factor driving the market.

The market is currently led by generic drugs which mainly include oral benzodiazepines (diazepam and lorazepam). Rectal diazepam is the only approved drug for use in U.S. and buccal midazolam in the European Union. Other drugs, such as diazepam (oral and intramuscular), midazolam (buccal, intranasal, intramuscular), lorazepam (oral, intranasal, sublingual), and progesterone are majorly used off label. The market is expected to be consolidated with a few major companies and a high market share.

Furthermore, in an attempt to curb healthcare expenditure, governments are making continuous efforts to reduce hospital stays and on-site treatment costs via outpatient care models, such as clinic and home healthcare. Emerging economies like India and China, are increasingly implementing such healthcare reform, which is expected to propel the growth of acute repetitive seizures market.

There are several routes of drug administration; out of which, the nasal route is the most preferred over others, such as buccal, rectal, and parenteral. The buccal route is preferred by caregivers and parents for children suffering from pediatric seizures since medication can be administered even outside the hospital.

Acute Repetitive Seizures Market Report Highlights

  • Global acute repetitive seizures market size was estimated at USD 3.15 billion in 2024 and is expected to register a CAGR of 12.7% over the forecast period
  • USL-261 dominated the market and accounted for a share of 44.5% in 2024, owing to its effectiveness as an intranasal treatment aimed at achieving rapid seizure control.
  • North America acute repetitive seizures market dominated the global market with a revenue share of 43.0% in 2024. Market growth in the region is driven by a high prevalence of epilepsy and neurological disorders, complemented by a robust healthcare infrastructure.
  • The acute repetitive seizures market in Japan dominated the Asia Pacific acute repetitive seizures market in 2024. The aging population, coupled with rising awareness of neurological disorders, stimulates demand for effective therapies.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Acute Repetitive Seizures Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
Chapter 4. Acute Repetitive Seizures Market: Product Business Analysis
4.1. Product Market Share, 2024 & 2030
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. USL-261
4.4.1. USL-261 Market, 2018 - 2030 (USD Million)
4.5. NRL-1
4.5.1. NRL-1 Market, 2018 - 2030 (USD Million)
4.6. AZ-002
4.6.1. AZ-002 Market, 2018 - 2030 (USD Million)
4.7. Diastat Rectal Gel
4.7.1. Diastat Rectal Gel Market, 2018 - 2030 (USD Million)
4.8. Others
4.8.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. Acute Repetitive Seizures Market: Regional Estimates & Trend Analysis
5.1. Regional Market Share Analysis, 2024 & 2030
5.2. Regional Market Dashboard
5.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
5.4. North America
5.4.1. North America Acute Repetitive Seizures Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
5.4.2. U.S.
5.4.2.1. Key Country Dynamics
5.4.2.2. Regulatory Framework
5.4.2.3. Competitive Insights
5.4.2.4. U.S. Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.4.3. Canada
5.4.3.1. Key Country Dynamics
5.4.3.2. Regulatory Framework
5.4.3.3. Competitive Insights
5.4.3.4. Canada Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.4.4. Mexico
5.4.4.1. Key Country Dynamics
5.4.4.2. Regulatory Framework
5.4.4.3. Competitive Insights
5.4.4.4. Mexico Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.5. Europe
5.5.1. Europe Acute Repetitive Seizures Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
5.5.2. UK
5.5.2.1. Key Country Dynamics
5.5.2.2. Regulatory Framework
5.5.2.3. Competitive Insights
5.5.2.4. UK Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.5.3. Germany
5.5.3.1. Key Country Dynamics
5.5.3.2. Regulatory Framework
5.5.3.3. Competitive Insights
5.5.3.4. Germany Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.5.4. France
5.5.4.1. Key Country Dynamics
5.5.4.2. Regulatory Framework
5.5.4.3. Competitive Insights
5.5.4.4. France Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.5.5. Italy
5.5.5.1. Key Country Dynamics
5.5.5.2. Regulatory Framework
5.5.5.3. Competitive Insights
5.5.5.4. Italy Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.5.6. Spain
5.5.6.1. Key Country Dynamics
5.5.6.2. Regulatory Framework
5.5.6.3. Competitive Insights
5.5.6.4. Spain Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.5.7. Norway
5.5.7.1. Key Country Dynamics
5.5.7.2. Regulatory Framework
5.5.7.3. Competitive Insights
5.5.7.4. Norway Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.5.8. Denmark
5.5.8.1. Key Country Dynamics
5.5.8.2. Regulatory Framework
5.5.8.3. Competitive Insights
5.5.8.4. Denmark Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.5.9. Sweden
5.5.9.1. Key Country Dynamics
5.5.9.2. Regulatory Framework
5.5.9.3. Competitive Insights
5.5.9.4. Sweden Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.6. Asia Pacific
5.6.1. Asia Pacific Acute Repetitive Seizures Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
5.6.2. Japan
5.6.2.1. Key Country Dynamics
5.6.2.2. Regulatory Framework
5.6.2.3. Competitive Insights
5.6.2.4. Japan Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.6.3. China
5.6.3.1. Key Country Dynamics
5.6.3.2. Regulatory Framework
5.6.3.3. Competitive Insights
5.6.3.4. China Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.6.4. India
5.6.4.1. Key Country Dynamics
5.6.4.2. Regulatory Framework
5.6.4.3. Competitive Insights
5.6.4.4. India Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.6.5. South Korea
5.6.5.1. Key Country Dynamics
5.6.5.2. Regulatory Framework
5.6.5.3. Competitive Insights
5.6.5.4. South Korea Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.6.6. Australia
5.6.6.1. Key Country Dynamics
5.6.6.2. Regulatory Framework
5.6.6.3. Competitive Insights
5.6.6.4. Australia Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.6.7. Thailand
5.6.7.1. Key Country Dynamics
5.6.7.2. Regulatory Framework
5.6.7.3. Competitive Insights
5.6.7.4. Thailand Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.7. Latin America
5.7.1. Latin America Acute Repetitive Seizures Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
5.7.2. Brazil
5.7.2.1. Key Country Dynamics
5.7.2.2. Regulatory Framework
5.7.2.3. Competitive Insights
5.7.2.4. Brazil Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.7.3. Argentina
5.7.3.1. Key Country Dynamics
5.7.3.2. Regulatory Framework
5.7.3.3. Competitive Insights
5.7.3.4. Argentina Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.8. MEA
5.8.1. MEA Acute Repetitive Seizures Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
5.8.2. South Africa
5.8.2.1. Key Country Dynamics
5.8.2.2. Regulatory Framework
5.8.2.3. Competitive Insights
5.8.2.4. South Africa Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.8.3. Saudi Arabia
5.8.3.1. Key Country Dynamics
5.8.3.2. Regulatory Framework
5.8.3.3. Competitive Insights
5.8.3.4. Saudi Arabia Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.8.4. UAE
5.8.4.1. Key Country Dynamics
5.8.4.2. Regulatory Framework
5.8.4.3. Competitive Insights
5.8.4.4. UAE Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.8.5. Kuwait
5.8.5.1. Key Country Dynamics
5.8.5.2. Regulatory Framework
5.8.5.3. Competitive Insights
5.8.5.4. Kuwait Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Participant Overview
6.2. Company Market Position Analysis
6.3. Company Categorization
6.4. Strategy Mapping
6.5. Company Profiles/Listing
6.5.1. UCB S.A., Belgium
6.5.1.1. Overview
6.5.1.2. Financial Performance
6.5.1.3. Product Benchmarking
6.5.1.4. Strategic Initiatives
6.5.2. Neurelis, Inc.
6.5.2.1. Overview
6.5.2.2. Financial Performance
6.5.2.3. Product Benchmarking
6.5.2.4. Strategic Initiatives
6.5.3. Bausch Health Companies Inc.
6.5.3.1. Overview
6.5.3.2. Financial Performance
6.5.3.3. Product Benchmarking
6.5.3.4. Strategic Initiatives
6.5.4. Grupo Ferrer Internacional, S.A.
6.5.4.1. Overview
6.5.4.2. Financial Performance
6.5.4.3. Product Benchmarking
6.5.4.4. Strategic Initiatives
6.5.5. SERB
6.5.5.1. Overview
6.5.5.2. Financial Performance
6.5.5.3. Product Benchmarking
6.5.5.4. Strategic Initiatives
List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. Global acute repetitive seizures market, by region, 2018 - 2030 (USD Million)
Table 4. Global acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 5. North America acute repetitive seizures market, by country, 2018 - 2030 (USD Million)
Table 6. North America acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 7. U.S. acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 8. Canada acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 9. Mexico acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 10. Europe acute repetitive seizures market, by country, 2018 - 2030 (USD Million)
Table 11. Europe acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 12. UK acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 13. Germany acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 14. France acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 15. Italy acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 16. Spain acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 17. Norway acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 18. Denmark acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 19. Sweden acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 20. Asia Pacific acute repetitive seizures market, by country, 2018 - 2030 (USD Million)
Table 21. Asia Pacific acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 22. Japan acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 23. China acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 24. India acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 25. Australia acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 26. South Korea acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 27. Thailand acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 28. Latin America acute repetitive seizures market, by country, 2018 - 2030 (USD Million)
Table 29. Latin America acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 30. Brazil acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 31. Argentina acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 32. Middle East & Africa Acute repetitive seizures market, by country, 2018 - 2030 (USD Million)
Table 33. Middle East & Africa acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 34. South Africa acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 35. Saudi Arabia acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 36. UAE acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 37. Kuwait acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Acute repetitive seizures market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Product outlook (USD Million)
Fig. 10 Competitive landscape
Fig. 11 Acute repetitive seizures market dynamics
Fig. 12 Acute repetitive seizures market: Porter’s five forces analysis
Fig. 13 Acute repetitive seizures market: PESTLE analysis
Fig. 14 Acute repetitive seizures market: Product segment dashboard
Fig. 15 Acute repetitive seizures market: Product market share analysis, 2024 & 2030
Fig. 16 USL-261 market, 2018 - 2030 (USD Million)
Fig. 17 NRL-1 market, 2018 - 2030 (USD Million)
Fig. 18 AZ-002 market, 2018 - 2030 (USD Million)
Fig. 19 Diastat rectal gel market, 2018 - 2030 (USD Million)
Fig. 20 Others market, 2018 - 2030 (USD Million)
Fig. 21 Acute repetitive seizures market revenue, by region
Fig. 22 Regional marketplace: Key takeaways
Fig. 23 Regional marketplace: Key takeaways
Fig. 24 North America acute repetitive seizures market, 2018 - 2030 (USD Million)
Fig. 25 U.S. country dynamics
Fig. 26 U.S. acute repetitive seizures market, 2018 - 2030 (USD Million)
Fig. 27 Canada country dynamics
Fig. 28 Canada acute repetitive seizures market, 2018 - 2030 (USD Million)
Fig. 29 Mexico country dynamics
Fig. 30 Mexico acute repetitive seizures market, 2018 - 2030 (USD Million)
Fig. 31 Europe acute repetitive seizures market, 2018 - 2030 (USD Million)
Fig. 32 UK country dynamics
Fig. 33 UK acute repetitive seizures market, 2018 - 2030 (USD Million)
Fig. 34 Germany country dynamics
Fig. 35 Germany acute repetitive seizures market, 2018 - 2030 (USD Million)
Fig. 36 France country dynamics
Fig. 37 France acute repetitive seizures market, 2018 - 2030 (USD Million)
Fig. 38 Italy country dynamics
Fig. 39 Italy acute repetitive seizures market, 2018 - 2030 (USD Million)
Fig. 40 Spain country dynamics
Fig. 41 Spain acute repetitive seizures market, 2018 - 2030 (USD Million)
Fig. 42 Norway country dynamics
Fig. 43 Norway acute repetitive seizures market, 2018 - 2030 (USD Million)
Fig. 44 Sweden country dynamics
Fig. 45 Sweden acute repetitive seizures market, 2018 - 2030 (USD Million)
Fig. 46 Denmark country dynamics
Fig. 47 Denmark acute repetitive seizures market, 2018 - 2030 (USD Million)
Fig. 48 Asia Pacific acute repetitive seizures market, 2018 - 2030 (USD Million)
Fig. 49 Japan country dynamics
Fig. 50 Japan acute repetitive seizures market, 2018 - 2030 (USD Million)
Fig. 51 China country dynamics
Fig. 52 China acute repetitive seizures market, 2018 - 2030 (USD Million)
Fig. 53 India country dynamics
Fig. 54 India acute repetitive seizures market, 2018 - 2030 (USD Million)
Fig. 55 Australia country dynamics
Fig. 56 Australia acute repetitive seizures market, 2018 - 2030 (USD Million)
Fig. 57 South Korea country dynamics
Fig. 58 South Korea acute repetitive seizures market, 2018 - 2030 (USD Million)
Fig. 59 Thailand country dynamics
Fig. 60 Thailand acute repetitive seizures market, 2018 - 2030 (USD Million)
Fig. 61 Latin America acute repetitive seizures market, 2018 - 2030 (USD Million)
Fig. 62 Brazil country dynamics
Fig. 63 Brazil acute repetitive seizures market, 2018 - 2030 (USD Million)
Fig. 64 Argentina country dynamics
Fig. 65 Argentina acute repetitive seizures market, 2018 - 2030 (USD Million)
Fig. 66 MEA acute repetitive seizures market, 2018 - 2030 (USD Million)
Fig. 67 South Africa country dynamics
Fig. 68 South Africa acute repetitive seizures market, 2018 - 2030 (USD Million)
Fig. 69 Saudi Arabia country dynamics
Fig. 70 Saudi Arabia acute repetitive seizures market, 2018 - 2030 (USD Million)
Fig. 71 UAE country dynamics
Fig. 72 UAE acute repetitive seizures market, 2018 - 2030 (USD Million)
Fig. 73 Kuwait country dynamics
Fig. 74 Kuwait acute repetitive seizures market, 2018 - 2030 (USD Million)
Fig. 75 Company categorization
Fig. 76 Company market position analysis
Fig. 77 Strategic framework

Companies Mentioned

  • UCB S.A., Belgium
  • Neurelis, Inc.
  • Bausch Health Companies Inc.
  • Grupo Ferrer Internacional, S.A.
  • SERB

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages100
PublishedJanuary 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 3.15 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.48 Billion
Compound Annual Growth Rate12.7%
Regions CoveredGlobal
No. of Companies Mentioned5

Related Topics

Related Reports

Acute Repetitive Seizures Market by Product, End-use - Global Forecast 2025-2030 - Product Image

Acute Repetitive Seizures Market by Product, End-use - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Acute Repetitive Seizures - Global Strategic Business Report - Product Image

Acute Repetitive Seizures - Global Strategic Business Report

  • Report
  • 92 Pages
  • Global
From
Acute Repetitive Seizures Market - Product Image

Acute Repetitive Seizures Market

  • Report
  • 200 Pages
  • Global
From
Dravet Syndrome Market by Offering, Seizure Type, Severity, End-Use - Global Forecast 2025-2030 - Product Image

Dravet Syndrome Market by Offering, Seizure Type, Severity, End-Use - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Epilepsy Drugs Market by Generation Type, Anti-Epileptics Drugs Type, Distribution Channel, and Region 2025-2033 - Product Image

Epilepsy Drugs Market by Generation Type, Anti-Epileptics Drugs Type, Distribution Channel, and Region 2025-2033

  • Report
  • 135 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.